Cathepsin K inhibitors

Details for Australian Patent Application No. 2006274959 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gabriel, Tobias; Bamberg, Joe Timothy

Agent Davies Collison Cave

Pub. Number AU-A-2006274959

PCT Pub. Number WO2007/014839

Priority 60/702,937 27.07.05 US

Filing date 17 July 2006

Wipo publication date 8 February 2007

International Classifications

C07D 209/04 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/404 (2006.01)

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/02 (2006.01) Antineoplastic agents

C07C 233/65 (2006.01) Carboxylic acid amides

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014839 Priority application(s): WO2007/014839

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274963-2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the GABAB-receptor

2006274945-A method for providing and analyzing an animal population having an essentially identical metabolome